Don't Miss The World's #1 Executive Networking Event"
Home ⟩ Insights
Insights
fda
1 min read • May 14, 2021
Compass Pathways Shares See Volume; Marijuana Moment Reports ‘FDA Clears Researchers To Study MDMA Use By Therapists Being Trained In Psychedelic Medicine’
3 min read • April 29, 2021
Jupiter Wellness Says Advances Clinical Pipeline Of CBD-Based Topical Treatments
3 min read • March 23, 2021
Neptune Wellness Solutions Inc. Announces Receipt Of Amendment To Its Health Canada License Permitting It To Sell Dried Cannabis Flower
6 min read • March 15, 2021
Lexaria Bioscience Highlights Progress In Hypertension Studies, Says All Five Studies Examining DehydraTECHTM CBD For Hypertension Are Underway
1 min read • March 8, 2021
cbdMD Reports Judge In California Class Action Suit Granted Its Motion, Stayed Action Until FDA Completes Its Rulemaking And/Or Congress Passes Legislation Related To Definitions, Marketing, Labeling Of CBD Products
4 min read • February 22, 2021
Benzinga Cannabis Hour Recap: The Importance Of Partnerships, Trustworthy Products, Being Recession-Proof
1 min read • February 3, 2021
Alan Brochstein, The 420 Investor, Says On Benzinga’s PreMarket Prep Says Thinks We’re Going To See ‘A Lot Of Development’ In Cannabis Science; Highlight’s GW Pharmaceuticals FDA Clearance
5 min read • January 26, 2021
FDA, FTC Crack Down On CBD Co.s For Marketing ‘Unapproved New Drugs,’ Making Unsubstantiated Health Claims
2 min read • December 23, 2020
FDA Sends Warning Letters To 5 CBD Companies
2 min read • November 3, 2020
GW Pharmaceuticals Revenue Hits $137M, Tests Another Cannabis Plant-Based Drug
3 min read • November 1, 2020
Does CBD Hit Different For Women? The FDA Wants To Know
1 min read • September 23, 2020
Tilray Shares Spike To Session High On Volume As Traders Circulate CBD Guidance Draft Doc From FDA Related To 100 mg/mL Solution Of Cannabidiol For In Vivo Bioequivalence Study; BZ NOTE: Tilray Not Specifically Mentioned In Draft Doc
Latest Headlines
View All
2 min read • June 2, 2026
Vireo Growth Reshapes Share Structure After Major Expansion Transactions
2 min read • June 2, 2026
Cannabis Giant, Verano, Joins Industry Peers In Reverse Stock Split Trend With 1-For-5 Consolidation
7 min read • June 2, 2026
Cannabis M&A Is Back, But Not The Way Investors Expected
4 min read • June 2, 2026
EXCLUSIVE: Virginia Governor Defends Cannabis Veto, Citing Timeline And Licensing Concerns
2 min read • June 1, 2026
Five-Month Hemp Enforcement Grace Period Ends In Oregon, Here’s What Businesses Must Know
3 min read • June 1, 2026
New Tennessee Hemp Rules Threaten THCa Market And Millions Of Dollars In Sales
3 min read • June 1, 2026
Robinhood Opens The Door To U.S. Cannabis Stocks
4 min read • June 1, 2026
Fireman Entrepreneur Award Builds Momentum Ahead of 2026 Announcement in Chicago
4 min read • June 1, 2026
Thin Legal Challenge from State AGs Could Still Complicate Federal Cannabis Rescheduling Effort
2 min read • May 29, 2026
Canopy Growth Bets On Europe As It Relaunches This Legacy Brand in Germany’s $1B Medical Cannabis Market
2 min read • May 29, 2026
Minnesota’s New Cannabis Bill Reshapes Market For Medical And Rec Operators
2 min read • May 28, 2026
New Study Tracks How Cannabis Beverages Are Replacing Alcohol In Everyday Settings
Browse By Channels
After-Hours Center
Analyst Color
Analyst Ratings
Andy Barr
Asia
Asset Sales
Be Your Own Boss
Binary Options
Biotech
Bonds
Broad U.S. Equity ETFs
Buybacks
california cannabis
Cannabis
cannabis earnings
cannabis farms
cannabis study
Christopher Dillis
CNBC
Commodities
Congress cannabis
Congress hemp
Contracts
Crowdsourcing
Cryptocurrency
Currency ETFs
Dividends
Downgrades
Earnings
Earnings Beats
Earnings Misses
Econ #s
Economics
Education
Emerging Market ETFs
Emerging Markets
Entertainment
Entrepreneurship
Equities
ESG
ETFs
Eurozone
Events
Exclusives
Fast Money
FDA
Federal Reserve
Financial Advisors
Financing
Fintech
first quarter earnings
Forex
Futures
Gaming
General
Global
Government
Guidance
Health Care
Hedge Funds
hemp bill
hemp legalization
hemp regulation
Hot
illegal cannabis farms
Initiation
Insider Trades
Insurance
Interview
intoxicating hemp-derived products
Intraday Update
IPOs
James Comer
Large Cap
Latin America
Legal
Long Ideas
M&A
Macro Economic Events
Macro Notification
Management
marijuana
Market Summary
Market-Moving Exclusives
Markets
Media
Mid Cap
Movers
Movers & Shakers
New ETFs
News
Offerings
Opinion
Options
Penny Stocks
Personal Finance
Politics
Pre-Market Outlook
Press Releases
Previews
Price Target
Psychedelics
Psychology
Real Estate
Regulations
REIT
Reiteration
Rescheduling
Restaurants
Retail Sales
Reviews
Rumors
SEC
Sector ETFs
Short Ideas
Short Sellers
Signals
Small Business
Small Cap
Small Cap Analysis
Social Media
Specialty ETFs
Sports
Sports Betting
Startups
Stock Split
Success Stories
Taxes
Tech
Technicals
THC
Top Stories
Topics
Trading Ideas
Travel
UC Berkeley Cannabis Research Center
unlicensed cannabis
Upgrades
WIIM
Join the Cannabis Revolution
Ready to access the most aggressive cannabis intelligence platform? Get started with IGNITE IT today.